483
Berman, Gary D., MD, Clinical InvestigatorFDA 483 - Berman, Gary D., MD, Clinical Investigator - March 29, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Berman, Gary D., MD, Clinical Investigator in Minneapolis, MN, revealed a significant issue regarding the conduct of investigations. The firm failed to adhere to the signed statement of investigator and investigational plan, specifically lacking an internal procedure for identifying, documenting, and resolving protocol deviations. This deficiency impacted the site's ability to manage eDiary entries and investigational product dose assignments.
Open in Dashboard
ID · 2246473f-22ff-433c-9181-eb69b3731327